financetom
Business
financetom
/
Business
/
Host Hotels & Resorts Q1 Adjusted FFO, Revenue Rise; Company Buys 1 Hotel Nashville, Embassy Suites For $530 Million
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Host Hotels & Resorts Q1 Adjusted FFO, Revenue Rise; Company Buys 1 Hotel Nashville, Embassy Suites For $530 Million
May 1, 2024 3:03 PM

05:32 PM EDT, 05/01/2024 (MT Newswires) -- Host Hotels & Resorts ( HST ) reported Q1 adjusted funds from operations Wednesday of $0.60, up from $0.55 a year earlier.

Analysts polled by Capital IQ expected adjusted FFO of $0.43 per share.

Revenue in the quarter ended March 31 rose to $1.47 billion from $1.38 billion a year earlier.

Analysts surveyed by Capital IQ expected $1.42 billion.

The company boosted 2024 adjusted FFO guidance to $1.97 to $2.05 per diluted share from $1.92 to $2.04. Analysts forecast adjusted FFO of $1.55.

The company boosted 2024 revenue guidance to $5.65 billion to $5.75 billion from $5.59 billion to $5.74 billion. Analysts polled by Capital IQ expect $5.59 billion.

Separately, the company said it acquired 1 Hotel Nashville and Embassy Suites by Hilton Nashville Downtown for $530 million in cash.

1 Hotel Nashville has 215 rooms, and Embassy Suites has 506 rooms, according to Host Hotels. The seller wasn't disclosed.

Bloomberg reported Monday a group of owners including a Starwood Capital Group affiliate, Crescent Real Estate and High Street Real Estate Partners were making the sale, according to people familiar with the matter.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
iPhone 17 outsells predecessor by 14% in early China, US sales, research firm says
iPhone 17 outsells predecessor by 14% in early China, US sales, research firm says
Oct 19, 2025
BEIJING (Reuters) -Apple's ( AAPL ) iPhone 17 series outperformed its predecessor in early sales in China and the United States, research firm Counterpoint said on Monday. The newer models outsold the iPhone 16 series by 14% during their first 10 days of availability in the two countries, Counterpoint said in a report. Sales of the base model iPhone 17...
Germany plans to order 15 more US-made F-35 jets, Der Spiegel reports
Germany plans to order 15 more US-made F-35 jets, Der Spiegel reports
Oct 19, 2025
BERLIN, Oct 20 (Reuters) - German Defence Minister Boris Pistorius intends to order an additional 15 F-35 fighter jets from U.S. manufacturer Lockheed Martin ( LMT ), according to confidential documents prepared for the parliament's budget committee, Der Spiegel reported on Monday. The supplementary procurement is listed among military projects, with planners estimating a budget requirement of 2.5 billion euros...
Warship builder TKMS makes stock market debut in latest sign of defence asset boom
Warship builder TKMS makes stock market debut in latest sign of defence asset boom
Oct 19, 2025
FRANKFURT, Oct 20 (Reuters) - Warship builder TKMS will make its stock market debut in Frankfurt on Monday, the latest move by parent Thyssenkrupp to simplify its structure and take advantage of growing demand globally for defence assets. Shares in the company will start trading around 0700 GMT on Frankfurt's stock exchange in a spin-off from Thyssenkruppthat will see the...
Accord Plasma B.V. Expands Global Plasma Therapy Capabilities with Acquisition of Prothya Biosolutions
Accord Plasma B.V. Expands Global Plasma Therapy Capabilities with Acquisition of Prothya Biosolutions
Oct 19, 2025
LONDON, Oct. 20, 2025 /PRNewswire/ -- Accord Plasma B.V., a subsidiary of Intas Pharmaceuticals, announced today that it has successfully completed the acquisition of Prothya Biosolutions Belgium BV and its subsidiaries. This strategic move enhances Accord B.V.'s commitment to improving global access to plasma-derived medicines and strengthens its ability to meet the increasing demand for life-saving plasma therapies worldwide. Prothya Biosolutions...
Copyright 2023-2026 - www.financetom.com All Rights Reserved